In this episode of Executive Insights for Life Sciences Innovators, we speak with Jason Kralic, CEO and co-founder of Tellus Therapeutics, a biotechnology company focused on developing novel therapies for neonatal brain injury.

Jason discusses how Tellus is building a translational biotech platform grounded in strong biological insight and disciplined execution, with a clear focus on addressing one of the most complex and underserved patient populations in medicine.

He shares insights from his career journey as a neuropharmacologist and life sciences business development leader, including how his experience in large pharma and biotech informs the way he evaluates scientific risk, platform focus, and company strategy.

We explore the challenges of translating science into the clinic, the realities of capital strategy and timing in today’s funding environment, and Jason’s perspective on what it takes to build biotech companies designed to endure.

This episode was streamed live on YouTube on January 9, 2026. Learn more at ⁠⁠genecoda.com⁠⁠.

In this episode of Executive Insights for Life Sciences Innovators, we speak with Karthik Sriram, Vice President of Financial Planning & Analysis at Parabilis Medicines, a biopharmaceutical company developing next-generation peptide therapeutics through its innovative Helicon™ platform.

Karthik discusses how Parabilis is applying platform science and strategic financial planning to advance medicines designed to deliver extraordinary outcomes for patients. He shares insights from his career journey, transitioning from biomedical engineering into corporate strategy and biotech finance, and highlights how FP&A plays a central role in aligning scientific priorities with operational execution.

We explore the company’s vision for the Helicon™ platform, the opportunities and challenges of scaling a clinical-stage organization, and the broader trends shaping the future of peptide therapeutics and biotech company-building.

This episode was streamed live on YouTube on December 8, 2025.Learn more at ⁠genecoda.com⁠.

In this episode of Executive Insights for Life Sciences Innovators, we speak with Jim Buck, President & CEO of Medcura, a medical device company advancing surgical safety through innovative hemostatic and wound treatment solutions.

Jim discusses how Medcura is addressing one of healthcare’s most persistent challenges, rapid and reliable bleeding control, through a platform built on biocompatible, naturally derived polymers. He shares insights from his leadership journey, the company’s path from R&D to commercialization, and how Medcura’s technology is helping surgeons and patients achieve better outcomes in both surgical and wound care settings.

This episode was streamed live on YouTube on October 6, 2025.

Learn more at genecoda.com.